CPIX
CPIX
NASDAQ · Pharmaceuticals

Cumberland Pharmaceuticals

$5.22
+0.21 (+4.19%)
As of Nov 7, 2:36 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +579.1% upside
Low Target $27.92
Average Target $35.45
High Target $53.56
Current Price $5.22
Current
$5.22
Target
$35.45
$27.92 $35.45 avg $53.56
Scenario Analysis
Bear Case
$27.92
434.9%
Low target
Base Case
$35.45
+579.1%
Avg target
Bull Case
$53.56
+926.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.28
-43.7% from high
52-Week Low
$1.85
+182.2% from low
Target vs 52W High
$35.45
+282.0% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%